Pancreatic Cancer Research

ResearcherUniversity Hospital Southampton NHS Foundation TrustActive in the last 2 years

John M. Primrose

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-2069-7605; OpenAlex author ID A5007992268, A5064952906. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
66
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies. Co-author DOI 10.1016/j.hpb.2025.12.001↗
  2. Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. Co-author DOI 10.1001/jamasurg.2025.4054↗
  3. The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial. Co-author DOI 10.1093/bjs/znae236↗
  4. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Co-author DOI 10.1016/j.lanepe.2023.100673↗
  5. Comment on "Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position". Last author DOI 10.1038/s41416-020-01132-9↗
  6. Intraoperative radiotherapy for pancreatic cancer: implementation and initial experience. Co-author DOI 10.1093/bjs/znab335↗
  7. Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence. Co-author DOI 10.1016/j.pan.2018.09.012↗

Closest collaborators

The 25 strongest of 66 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thilo Hackert · 2 shared papers, 2024–2026 · strength 0.34
  2. Bas Groot Koerkamp · 2 shared papers, 2024–2026 · strength 0.34
  3. Marc G. Besselink · 2 shared papers, 2024–2026 · strength 0.34
  4. Mohammad Abu Hilal · 2 shared papers, 2024–2026 · strength 0.34
  5. Ali Raza Arshad · 2 shared papers, 2021 · strength 0.31
  6. Matthew H. G. Katz · 1 shared paper, 2026 · strength 0.20
  7. Rutger T. Theijse · 1 shared paper, 2026 · strength 0.20
  8. Sohei Satoi · 1 shared paper, 2026 · strength 0.20
  9. Ingmar Florin Rompen · 1 shared paper, 2026 · strength 0.20
  10. Patrik Larsson · 1 shared paper, 2026 · strength 0.20
  11. Nicholas Joseph Zyromski · 1 shared paper, 2026 · strength 0.20
  12. Atsushi Oba · 1 shared paper, 2026 · strength 0.20
  13. Shailesh Vinayak Shrikhande · 1 shared paper, 2026 · strength 0.20
  14. José Manuel Ramia · 1 shared paper, 2026 · strength 0.20
  15. Poya Ghorbani · 1 shared paper, 2026 · strength 0.20
  16. Thomas F. Stoop · 1 shared paper, 2026 · strength 0.20
  17. Elena B. Rangelova · 1 shared paper, 2026 · strength 0.20
  18. Roeland F. de Wilde · 1 shared paper, 2026 · strength 0.20
  19. Christopher Lee Wolfgang · 1 shared paper, 2026 · strength 0.20
  20. Jin-Young Jang · 1 shared paper, 2026 · strength 0.20
  21. Marco Del Chiaro · 1 shared paper, 2026 · strength 0.20
  22. Mark Joseph Truty · 1 shared paper, 2026 · strength 0.20
  23. Jan Sven David Mieog · 1 shared paper, 2026 · strength 0.20
  24. Casper H.J. van Eijck · 1 shared paper, 2026 · strength 0.20
  25. Richard David Schulick · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.